Mini-dose glucagon (MDG) has been considered as an alternative to oral carbohydrate intake for mild or impending hypoglycemia without breaking the fast; however, current evidence is limited and remains preliminary, derived largely from small pilot studies and limited real-world data. This evidence concerns the gene GCG and Hypoglycemia.